Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
An FDA advisory panel is meeting today to consider if millions of younger children, ages 5 to 11, should be eligible for Pfizer’s COVID-19 vaccine. CBS News’ Laura Podesta joins “CBSN AM” with the latest.
View CBS News In
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.